Maintenance work on the ZORA databases is scheduled for Wednesday 22 May 2019 from 20:00-22:00. During this period ZORA and JDB will not be available. Thank you for your understanding.
Fritzsche, F R; Jung, M; Tölle, A; Wild, P; Hartmann, A; Wassermann, K; Rabien, A; Lein, M; Dietel, M; Pilarsky, C; Calvano, D; Grützmann, R; Jung, K; Kristiansen, G (2008). ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. European Urology, 54(5):1097-1108.
Fritzsche, F R; Wassermann, K; Jung, M; Tölle, A; Kristiansen, I; Lein, M; Johannsen, M; Dietel, M; Jung, K; Kristiansen, G (2008). ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer, 8:179.
Kristiansen, G; Fritzsche, F R; Wassermann, K; Jäger, C; Tölle, A; Lein, M; Stephan, C; Jung, K; Pilarsky, C; Dietel, M; Moch, H (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. British Journal of Cancer, 99(6):939-948.